The Science Behind Hemp & Cannabinoids featuring Dr. Stuart Titus

Join us for an in-person, evidence-focused exploration of hemp and cannabinoids. Dr. Stuart Titus will present current research developments, clinical insights, and emerging trends shaping the therapeutic landscape. This session offers an opportunity to deepen your understanding, engage with peers, and gain perspective from a respected expert in the field. Discover how advancements in cannabinoid science may support future applications in patient care.

Who he is

• Dr. Stuart Titus, Ph.D., is best known as a pioneer and long-time leader in the cannabis/hemp industry. Investing Experts+2ideamensch+2
• He served for many years as President and CEO of Medical Marijuana, Inc. (often “MJNA”), which was the first publicly traded cannabis company in the United States. GlobeNewswire+2GlobeNewswire+2

Background & Career Path

• Before entering the cannabis/hemp space, Titus spent 11 years working on Wall Street as a bond trader — rising to the level of Vice President at CS First Boston. Investing Experts+2ideamensch+2
• After finance, he pivoted into health and wellness: he trained as a physiotherapist and reportedly ran clinics focused on integrative pain management and injury rehabilitation for about 15 years — treating thousands of patients. GlobeNewswire+2infinitecal.com+2
• Academically, he earned an undergraduate degree in Economics (with a minor in Business Administration) from Rollins College (Winter Park, Florida). GlobeNewswire+1 He later earned a Ph.D. from Open International University — an institution affiliated with the World Health Organization (WHO). medicaljane.com+1

Involvement in Cannabis / Hemp & CBD

• Titus was among the earliest investors in Medical Marijuana, Inc. — reportedly the “seventh investor” during its seed financing. GlobeNewswire+2ideamensch+2
• Under his leadership, the company — and its portfolio of subsidiaries (like HempMeds, Kannaway, and other related firms) — helped bring hemp-derived CBD (cannabidiol) products to mainstream markets across the United States and internationally. ideamensch+2Medium+2
• He has also been personally involved in advocating for CBD — including providing testimony to the U.S. Food and Drug Administration (FDA) regarding how hemp-derived CBD should be regulated and the potential wellness benefits. Medical Marijuana, Inc.+1
• More broadly, he’s been described as a cannabinoid researcher and educator, helping explain and promote the science (and potential therapeutic use) behind cannabinoids and the body’s endocannabinoid system. ideamensch+2Medical Marijuana, Inc.+2

Recognition & Later Career Status

• Under his leadership, Medical Marijuana, Inc. gained significant recognition: in 2021, he was named “2020 Best Business Leader in the United States” by Global Brands Magazine. GlobeNewswire+1
• In June 2021, he stepped down as CEO and President — entering “semi-retirement”. GlobeNewswire He continues to serve the company as a consultant, spokesperson, product expert and cannabis educator under a multiyear agreement. GlobeNewswire

Why He Matters / What He’s Known For

• Dr. Titus is widely regarded as a pioneer who helped move CBD and hemp-derived products from fringe or underground status into mainstream consumer markets — both within the U.S. and internationally.
• His background bridging finance, integrative medicine, and business gives him a unique vantage — combining business acumen with an interest in wellness, which helped shape the modern hemp/CBD industry.
• His public advocacy and testimony at regulatory hearings helped influence how policymakers and regulators view CBD and cannabis-derived products.